Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Burberry shares jump on cost savings as 1,700 jobs to go

(Sharecast News) - Shares in Burberry jumped on Wednesday as the troubled luxury brand swung to a full-year loss amid a slump in revenue and warned that 1,700 jobs could be at risk as part of its ongoing turnaround plan. The company posted a £66m pre-tax loss for the year to March 29 compared to a profit of £418m a year ago. Revenue fell 17% to £2.46bn.

Sales fell less than expected in the fourth quarter, down 6% in the three months to March against consensus estimates of 7%. Shares in the company were up almost 15% in London trade.

It also revealed that organisational changes as part of a turnaround plan could see it slash 1,700 jobs globally as part of a broader cost-cutting programme including procurement and real estate which are estimated to lead to cost savings of £60m on top of the £40m already announced by chief executive Joshua Schulman.

"We are still in the early stages of our turnaround. The current macroeconomic environment has become more uncertain in light of geopolitical developments," the company said on Wednesday.

Schulman said most of the 1,700 job cuts would be at the group's head offices around the world, but roles would also go by reorganising staff rotas in stores and dropping one shift at its factory in Castleford.

He said the change in Castleford, which is expected to affect about 150 jobs, came ahead of a "significant investment" in the second half of this year in the factory.

"For a long time we have had over capacity at that facility and that's simply not sustainable at this point. We are making this change to safeguard our UK manufacturing and will be making a significant investment in renovating the factory," he said.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.